Create an account or log in to participate in this activity
Physicians, nurses, PAs, and other members of the healthcare team.
At the conclusion of this activity, participants should be better able to:
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Boston University Chobanian & Avedisian School of Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Contact Hours: 1.25; of which 0 are eligible for pharmacology credit.
This program meets the criteria of the Massachusetts Board of Registration in Medicine for risk management study.
This program meets the criteria of the Massachusetts Board of Registration in Medicine for opioid education.
This activity is supported through a contract with the Massachusetts Department of Public Health, Bureau of Substance Addiction Services.
Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors and anyone who may be in control of content have been mitigated.
Daniel P. Alford, MD, MPH (CME Course Director)
Professor of Medicine
Associate Dean, Continuing Medical Education
Boston University Chobanian & Avedisian School of Medicine
Director, Clinical Addiction Research and Education (CARE) Unit
Boston Medical Center
Erica Bial, MD, MS
Interventional Pain Specialist
Private Practice
Christopher Shanahan, MD, MPH
MCSTAP Medical Director
Boston Medical Center
Alex Walley, MD
Addiction Specialist, Boston Medical Center
Medical Director, Bureau of Substance Addiction Services
Massachusetts Department of Public Health
Faculty members have no relevant relationships to disclose. Faculty members do not plan on discussing unlabeled/investigational uses of a commercial product.
Ilana Hardesty, Senior Operations Manager, Boston University Chobanian & Avedisian School of Medicine CME/CNE Office, has no relevant financial relationships to disclose.
Kristin Wason, NP, Boston University Chobanian & Avedisian School of Medicine/Boston Medical Center, Nurse Advisor, has no relevant financial relationships to disclose.
Date of Release: July 31, 2024
Date of Expiration: July 30, 2025
THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED.
SCOPE of Pain
© 2024 Trustees of Boston University. Site by Root802.